Stay updated on XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page.

Latest updates to the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded new date references and a study-status/oversight label (IPDSharing); removed an earlier date. Overall, a minor update to project/status information rather than core content.SummaryDifference1%

- Check19 days agoChange DetectedMajor update to core page content: adds a government funding notice and current operating status details, plus a version bump to v3.2.0; removes the previous v3.1.0 reference.SummaryDifference12%

- Check26 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%

- Check41 days agoChange DetectedVersion updated to v3.0.2 and the Back to Top control was removed. No substantive changes to core content, pricing, stock, or other key data.SummaryDifference0.7%

- Check48 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.7%

- Check55 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as multiple study status updates spanning from 2022 to 2025.SummaryDifference18%

Stay in the know with updates to XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page.